Elacridar hydrochloride
Tocris Bioscience | Catalog # 4646
Key Product Details
Description
Alternative Names
Product Description
Elacridar hydrochloride is a P-glycoprotein (P-gp/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) inhibitor. Elacridar hydrochloride blocks P-gp-mediated multidrug resistance (MDR) of the cytotoxic drugs doxorubicin (Cat. No. 2252) and vincristine (Cat. No. 1257) in CHRC5 cells. Orally active.
Licensing Information
Sold for research purposes under agreement from GlaxoSmithKline.
Product Specifications for Elacridar hydrochloride
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 12 | 20 |
Preparing Stock Solutions for Elacridar hydrochloride
The following data is based on the product molecular weight 600.10.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 8.33 mL | 41.66 mL | 83.32 mL |
| 1 mM | 1.67 mL | 8.33 mL | 16.66 mL |
| 2 mM | 0.83 mL | 4.17 mL | 8.33 mL |
| 10 mM | 0.17 mL | 0.83 mL | 1.67 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 4 publications citing the usage of this product.
- Myer The chemosensitizing potential of GF120918 is independent of the magnitude of P-glycoprotein-mediated resistance to conventional chemotherapeutic agents in a small cell lung cancer line. Oncol Rep. 1999 PMID: 9864431
- Durmus Oral availability and brain penetration of the B-RAFV600E inhibitor vemurafenib can be enhanced by the P-GLYCOprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar. Mol.Pharm. 2012 PMID: 23020847
- Hyafil In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 1993 PMID: 8402633
Product Documents for Elacridar hydrochloride
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for Elacridar hydrochloride
For research use only
Citations for Elacridar hydrochloride
Customer Reviews for Elacridar hydrochloride (1)
Have you used Elacridar hydrochloride?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
-
Species: MouseAssay Type: In VitroCell Line/Tissue: Endothelial cell, AstrocytesVerified Customer | Posted 10/29/2018Elacridar is used as P glycoprotein transporter blocker to enhance drug penetration in iPsc derived endothelial cell co cultured with ALS astrocytes.
There are no reviews that match your criteria.